Flanagan W. Michael
Chief Scientific Officer
Flanagan W. Michael has filed 3 SEC Form 4 filings (4 transaction rows) across 2 companies, including RNAM, RNA, with disclosures dating back to 2026. 3 of those filings fall inside the rolling window. Most recent filing: Feb 27, 2026.
Companies traded
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$645K
reported sales (SEC code S)
Companies
2
in the rolling window